Literature DB >> 14563095

Antenatal detection of mosaic trisomy 9 by ultrasound: a case report and literature review.

F Stipoljev1, M Kos, M Kos, B Miskovi, R Matijevic, T Hafner, A Kurjak.   

Abstract

This paper presents a fetus with mosaic trisomy 9 diagnosed by chorionic villus sampling and confirmed by cordocentesis, and compares this case with published cases in order better to define the ultrasound markers confined to trisomy 9 syndrome. Detailed fetal ultrasound examination was carried out, revealing shortened femur, placental cysts and oligohydramnios. All published trisomy 9 cases with abnormal ultrasound findings were extracted from the MEDLINE database in the period from 1973 to 2002. We found 12 non-mosaic and 13 mosaic cases, including our case. The most frequent ultrasound abnormalities included characteristic cardiac, skeletal, craniofacial and central nervous system malformations. Intrauterine growth restriction and single umbilical artery were prevalent non-specific findings in both non-mosaic and mosaic groups. Parental chromosomal variations, as in our case, were not uncommon findings. When a fetus shows structural anomalies suggesting the presence of trisomy 9, karyotyping should be performed on both chorionic villi or amniocytes and fetal blood lymphocytes to enable a correct diagnosis to be made.

Entities:  

Mesh:

Year:  2003        PMID: 14563095     DOI: 10.1080/jmf.14.1.65.69

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

1.  Clinical manifestations in trisomy 9.

Authors:  T P Kannan; S Hemlatha; R Ankathil; B A Zilfalil
Journal:  Indian J Pediatr       Date:  2009-05-27       Impact factor: 1.967

Review 2.  Trisomy 9 mosaic syndrome: Sixteen additional patients with new and/or less commonly reported features, literature review, and suggested clinical guidelines.

Authors:  Mindy Li; Jennifer Glass; Xiaoli Du; Holly Dubbs; Margaret Horton Harr; Marni Falk; Teresa Smolarek; Robert J Hopkin; Elaine Zackai; Sarah E Sheppard
Journal:  Am J Med Genet A       Date:  2021-05-10       Impact factor: 2.578

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.